SCHEMBL14213532

SCHEMBL14213532

CCOc1nsc(N2CCSCC2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.37
MAPK1 P28482 1/20 0.37
L3MBTL1 Q9Y468 4/20 0.36
ALDH1A1 P00352 3/20 0.36
TSHR P16473 3/20 0.36
RAB9A P51151 4/20 0.34
NPC1 O15118 2/20 0.34
LMNA P02545 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
NFKB1 P19838 1/20 0.33
CYP2C19 P33261 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14213045 0.85 ALDH1A1 (0.46) SMN1; SMN2MAPK1L3MBTL1ALDH1A1TSHR
SCHEMBL14213528 0.81 ALDH1A1 (0.59) SMN1; SMN2MAPK1L3MBTL1ALDH1A1TSHR
SCHEMBL4849186 0.81 MMP1 (0.32) RAB9ANPC1
SCHEMBL14182485 0.77 RAB9A (0.34) L3MBTL1RAB9ANPC1AR
SCHEMBL14213542 0.75 TSHR (0.41) SMN1; SMN2MAPK1L3MBTL1ALDH1A1TSHR
SCHEMBL14213022 0.74 SLC29A1 (0.36) SMN1; SMN2MAPK1ALDH1A1TSHRRAB9A
SCHEMBL14213357 0.74 ALDH1A1 (0.37) SMN1; SMN2MAPK1L3MBTL1ALDH1A1TSHR
SCHEMBL14213521 0.73 SLC29A1 (0.38) SMN1; SMN2ALDH1A1TSHRRAB9ANPC1
SCHEMBL14182486 0.72 DPP4 (0.44) L3MBTL1ALDH1A1TSHRRAB9ANPC1
SCHEMBL14213541 0.71 SMN1; SMN2 (0.44) SMN1; SMN2MAPK1ALDH1A1TSHRRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371746-B2 1,2,4-Thiadiazole compounds and pests controlling composition containing the same SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2008-05-13 US disclosed
US-20070004722-A1 1,2,4-Thiadazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004722-A1 1,2,4-Thiadazole compounds and use thereof CYP4F3, CYP4B1, CYP4X1 SMN1; SMN2 3920/4885MAPK1 948/4885L3MBTL1 203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.